Macquarie Group’s Fractyl Health GUTS Stock Holding History

Macquarie Group’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-966	Closed	-$7	–	2168
2024 Q1	$7	Buy	+966	New	+$8.13K	﹤0.01%	1758

Other funds holding GUTS

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Macquarie Group's GUTS Position: Q2 2024 in Review

Macquarie Group sold out of Fractyl Health (GUTS) in Q2 2024, closing a stake of 966 shares — an estimated $7 sold.

Macquarie Group first reported a position in GUTS in Q1 2024 and held it in 1 quarter. The position peaked at $7 in Q1 2024. 44 funds tracked by Wall St. Rank hold GUTS as of Q2 2024.

Macquarie Group reported no remaining Fractyl Health position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 966 Fractyl Health shares in Q2 2024, an estimated $7.
Macquarie Group first reported a position in Fractyl Health in Q1 2024 and held it in 1 quarter.
Macquarie Group's Fractyl Health position peaked at $7 in Q1 2024.
44 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.